ANI Pharmaceuticals (ANIP) Short Interest Ratio & Short Volume $92.53 +0.65 (+0.71%) Closing price 04:00 PM EasternExtended Trading$92.58 +0.05 (+0.05%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ANI Pharmaceuticals Short Interest DataANI Pharmaceuticals (ANIP) has a short interest of 2.21 million shares, representing 11.48% of the float (the number of shares available for trading by the public). This marks a 3.76% increase in short interest from the previous month. The short interest ratio (days to cover) is 5.6, indicating that it would take 5.6 days of the average trading volume of 374,129 shares to cover all short positions.Current Short Interest2,210,000 sharesPrevious Short Interest2,130,000 sharesChange Vs. Previous Month+3.76%Dollar Volume Sold Short$140.00 millionShort Interest Ratio5.6 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares21,700,000 sharesShort Percent of Float11.48%Today's Trading Volume477,316 sharesAverage Trading Volume374,129 sharesToday's Volume Vs. Average128% Short Selling ANI Pharmaceuticals? Sign up to receive the latest short interest report for ANI Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartANIP Short Interest Over TimeANIP Days to Cover Over TimeANIP Percentage of Float Shorted Over Time ANI Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20252,210,000 shares $140.00 million +3.8%11.5%5.6 $63.35 7/15/20252,130,000 shares $136.32 million +6.0%N/A6 $64.00 6/30/20252,010,000 shares $131.15 million No Change10.4%5.5 $65.25 6/15/20252,010,000 shares $125.75 million +5.8%10.4%5.2 $62.56 5/31/20251,900,000 shares $112.59 million +2.2%10.3%4.7 $59.26 5/15/20251,860,000 shares $110.73 million -7.0%10.1%4.5 $59.53 4/30/20252,000,000 shares $141.64 million -15.3%N/A5.3 $70.82 4/15/20252,360,000 shares $164.14 million -10.6%12.9%7.7 $69.55 3/31/20252,640,000 shares $176.75 million +2.3%14.4%8.9 $66.95 3/15/20252,580,000 shares $161.22 million +0.8%14.1%9.7 $62.49 Get the Latest News and Ratings for ANIP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ANI Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/28/20252,560,000 shares $158.44 million No Change13.9%10.3 $61.89 2/15/20252,560,000 shares $150.84 million +13.3%13.9%11 $58.92 1/31/20252,260,000 shares $132.53 million -1.3%N/A9.1 $58.64 1/15/20252,290,000 shares $129.50 million +6.5%N/A8.9 $56.55 12/31/20242,150,000 shares $118.85 million -8.5%N/A8.5 $55.28 12/15/20242,350,000 shares $132.99 million +27.7%N/A9.3 $56.59 11/30/20241,840,000 shares $105.30 million -12.8%N/A6.3 $57.23 11/15/20242,110,000 shares $119.38 million -2.3%N/A6.7 $56.58 10/31/20242,160,000 shares $123.65 million +5.4%N/A7 $57.25 10/15/20242,050,000 shares $120.13 million -9.7%N/A5.8 $58.60 9/30/20242,270,000 shares $135.43 million +2.3%N/A6.5 $59.66 9/15/20242,220,000 shares $129.89 million -8.3%N/A6.4 $58.51 8/31/20242,420,000 shares $154.28 million +44.9%N/A8.1 $63.75 8/15/20241,670,000 shares $102.04 million +439.8%N/A6.8 $61.10 7/31/2024309,400 shares $20.33 million -20.7%N/A1.3 $65.72 7/15/2024390,000 shares $24.66 million +5.7%N/A2.5 $63.22 6/30/2024369,000 shares $23.50 million -2.0%N/A2.4 $63.68 6/15/2024376,500 shares $23.58 million +11.0%N/A2.5 $62.62 5/31/2024339,100 shares $22.01 million +65.9%N/A2.2 $64.90 5/15/2024204,400 shares $13.25 million -11.1%N/A1.3 $64.82 4/30/2024229,900 shares $15.17 million +7.7%N/A1.6 $66.00 4/15/2024213,500 shares $14.16 million +8.4%N/A1.5 $66.30 3/31/2024197,000 shares $13.62 million -24.7%N/A1.4 $69.13 3/15/2024261,600 shares $17.27 million +5.0%N/A1.9 $66.00 2/29/2024249,100 shares $16.86 million +16.7%N/A1.8 $67.67 2/15/2024213,400 shares $12.28 million -11.9%N/A1.7 $57.55 1/31/2024242,200 shares $13.52 million +8.2%N/A1.6 $55.82 1/15/2024223,900 shares $12.70 million -15.2%N/A1.4 $56.74 12/31/2023264,000 shares $14.56 million -34.0%N/A1.5 $55.14 12/15/2023399,700 shares $21.15 million -0.5%N/A2.3 $52.91Think you missed gold’s boom? Think again (Ad)If you've been watching gold's historic run and wondering if it's too late… I've got good news. Because there's a $15 fund tied directly to gold's surge that's still paying massive income… Up to 64% annually — with payouts every 30 days.Click here to see how to secure the next payout before it's too late. 11/30/2023401,700 shares $20.01 million +6.6%N/A2.4 $49.81 11/15/2023376,800 shares $19.71 million -11.0%N/A2.2 $52.30 10/31/2023423,400 shares $26.14 million +1.9%N/A2.2 $61.74 10/15/2023415,400 shares $23.95 million -6.4%N/A2.5 $57.66 9/30/2023444,000 shares $25.78 million +44.9%N/A2.8 $58.06 9/15/2023306,500 shares $19.12 million +15.8%N/A2 $62.39 8/31/2023264,800 shares $17.05 million -7.5%N/A1.7 $64.39 8/15/2023286,200 shares $17.71 million -15.7%N/A2 $61.89 7/31/2023339,300 shares $17.83 million -2.0%N/A2.3 $52.55 7/15/2023346,200 shares $17.41 million +3.8%N/A2.5 $50.28 6/30/2023333,700 shares $17.96 million +21.8%N/A2.5 $53.83 6/15/2023274,000 shares $13.89 million +7.2%N/A2.2 $50.71 5/31/2023255,600 shares $11.54 million -24.1%N/A2.3 $45.14 5/15/2023336,900 shares $13.77 million -15.9%N/A3.2 $40.88 4/30/2023400,700 shares $15.11 million +14.7%N/A5.8 $37.72 4/15/2023349,500 shares $13.43 million +4.7%N/A5.5 $38.42 3/31/2023333,800 shares $13.26 million -3.9%2.6%5.1 $39.72 3/15/2023347,200 shares $13.89 million +15.3%N/A5.1 $40.01 2/28/2023301,100 shares $12.60 million -4.6%N/A4.5 $41.84 2/15/2023315,500 shares $14.21 million -4.3%N/A4.7 $45.04 1/31/2023329,600 shares $14.74 million +1.2%N/A4.5 $44.73 1/15/2023325,700 shares $14.31 million -4.9%N/A4.6 $43.95 12/30/2022342,300 shares $13.77 million -20.0%N/A5 $40.23 12/15/2022427,700 shares $16.78 million -4.3%N/A6.5 $39.24 11/30/2022447,000 shares $18.75 million -11.0%N/A6.7 $41.95 11/15/2022502,200 shares $18.38 million -12.5%4.0%7.5 $36.60 10/31/2022573,700 shares $22.14 million +1.0%4.6%8.8 $38.59 10/15/2022568,000 shares $18.87 million -15.3%4.5%8.4 $33.22 9/30/2022670,700 shares $21.56 million -2.7%5.4%9.1 $32.14 9/15/2022689,200 shares $25.10 million -1.0%5.5%8 $36.42 8/31/2022696,200 shares $25.68 million +4.4%5.6%7.6 $36.89 8/15/2022667,100 shares $25.24 million -2.6%5.4%7.1 $37.84 7/31/2022685,000 shares $23.46 million -4.8%7.8%6.6 $34.25 7/15/2022719,400 shares $22.55 million -12.3%8.2%6.5 $31.35 6/30/2022820,000 shares $24.33 million +17.9%9.3%7.3 $29.67 6/15/2022695,400 shares $16.53 million +2.5%7.9%6 $23.77 5/31/2022678,700 shares $20.53 million +6.1%5.5%4.8 $30.25 5/15/2022639,900 shares $16.94 million +9.5%5.2%4.4 $26.47 4/30/2022584,300 shares $17.24 million +9.3%4.7%4.2 $29.51 4/15/2022534,600 shares $17.19 million +4.2%4.3%3.8 $32.16 3/31/2022513,200 shares $14.43 million +65.0%4.2%3.9 $28.11 3/15/2022311,000 shares $9.02 million -12.0%2.5%2.3 $29.01 2/28/2022353,400 shares $13.23 million +8.6%2.9%3.1 $37.45 2/15/2022325,300 shares $13.09 million -8.8%2.7%2.7 $40.25 1/31/2022356,700 shares $14.42 million +22.5%2.9%2.6 $40.42 1/15/2022291,100 shares $12.53 million +13.3%2.4%1.3 $43.03 12/31/2021257,000 shares $11.84 million +3.1%2.1%1.1 $46.08 12/15/2021249,200 shares $11.68 million +15.8%2.1%1.1 $46.86 11/30/2021215,200 shares $8.85 million -7.9%1.9%1.1 $41.14 11/15/2021233,600 shares $10.51 million -53.1%2.1%1.3 $45.01Think you missed gold’s boom? Think again (Ad)If you've been watching gold's historic run and wondering if it's too late… I've got good news. Because there's a $15 fund tied directly to gold's surge that's still paying massive income… Up to 64% annually — with payouts every 30 days.Click here to see how to secure the next payout before it's too late. 10/29/2021497,700 shares $18.60 million +4.3%4.5%3 $37.38 10/15/2021477,200 shares $18.39 million -4.9%4.8%8 $38.54 9/30/2021501,900 shares $16.47 million -0.3%5.1%8.5 $32.82 9/15/2021503,200 shares $13.78 million +5.4%5.1%8.3 $27.39 8/31/2021477,300 shares $14.48 million +2.5%4.8%8.1 $30.33 8/13/2021465,600 shares $13.99 million +2.2%4.7%8.1 $30.05 7/30/2021455,400 shares $15.45 million -1.7%4.6%7.5 $33.93 7/15/2021463,300 shares $15.28 million +5.5%4.7%7.9 $32.98 6/30/2021439,300 shares $15.40 million -11.9%4.5%7.4 $35.05 6/15/2021498,500 shares $17.07 million -1.5%5.1%8.6 $34.24 5/28/2021505,900 shares $17.38 million +3.9%5.1%8.6 $34.35 5/14/2021486,900 shares $16.33 million -3.0%4.9%8 $33.53 4/30/2021502,000 shares $16.74 million -4.8%5.1%8.4 $33.35 4/15/2021527,300 shares $17.77 million +3.1%5.5%9.4 $33.70 3/31/2021511,700 shares $16.86 million -3.1%5.5%9.1 $32.94 3/15/2021528,100 shares $17.08 million -2.7%5.6%8.2 $32.34 2/26/2021542,800 shares $16.07 million +4.1%5.7%8.7 $29.60 2/12/2021521,300 shares $16.30 million -2.6%5.5%8.1 $31.26 1/29/2021535,100 shares $15.80 million +4.1%5.6%7.5 $29.52 1/15/2021514,000 shares $16.50 million -8.6%5.4%7 $32.10 12/31/2020562,500 shares $16.11 million -6.3%5.9%7.7 $28.64 12/15/2020600,400 shares $17.98 million -2.1%6.3%8.5 $29.95 11/30/2020613,000 shares $18.07 million +2.1%6.4%8.9 $29.48 11/15/2020600,700 shares $16.70 million -8.2%6.3%8.6 $27.80 10/30/2020654,200 shares $17.22 million +22.5%6.9%9.1 $26.32 10/15/2020534,100 shares $15.49 million -2.9%5.6%7.2 $29.00 9/30/2020550,000 shares $15.52 million -0.3%5.8%6.6 $28.21 9/15/2020551,800 shares $15.64 million -10.4%5.8%5.8 $28.35 8/31/2020615,700 shares $19.31 million -1.6%6.5%5.8 $31.36 ANIP Short Interest - Frequently Asked Questions What is ANI Pharmaceuticals' current short interest? Short interest is the volume of ANI Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of July 31st, investors have sold 2,210,000 shares of ANIP short. 11.48% of ANI Pharmaceuticals' shares are currently sold short. Learn More on ANI Pharmaceuticals' current short interest. What is a good short interest ratio for ANI Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ANIP shares currently have a short interest ratio of 6.0. Learn More on ANI Pharmaceuticals's short interest ratio. Which institutional investors are shorting ANI Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ANI Pharmaceuticals: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for ANI Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.48% of ANI Pharmaceuticals' floating shares are currently sold short. Is ANI Pharmaceuticals' short interest increasing or decreasing? ANI Pharmaceuticals saw a increase in short interest in the month of July. As of July 31st, there was short interest totaling 2,210,000 shares, an increase of 3.8% from the previous total of 2,130,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does ANI Pharmaceuticals' short interest compare to its competitors? 11.48% of ANI Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to ANI Pharmaceuticals: ADMA Biologics Inc (5.96%), Annovis Bio, Inc. (14.19%), Grifols, S.A. (1.21%), Legend Biotech Corporation Sponsored ADR (4.26%), Revolution Medicines, Inc. (8.12%), Rhythm Pharmaceuticals, Inc. (7.23%), Avidity Biosciences, Inc. (13.10%), Nuvalent, Inc. (11.99%), Axsome Therapeutics, Inc. (9.47%), CRISPR Therapeutics AG (26.94%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short ANI Pharmaceuticals stock? Short selling ANIP is an investing strategy that aims to generate trading profit from ANI Pharmaceuticals as its price is falling. ANIP shares are trading down $0.24 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ANI Pharmaceuticals? A short squeeze for ANI Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ANIP, which in turn drives the price of the stock up even further. How often is ANI Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ANIP, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies ADMA Biologics Short Interest Annovis Bio Short Interest Grifols Short Interest Legend Biotech Short Interest Revolution Medicines Short Interest Rhythm Pharmaceuticals Short Interest Avidity Biosciences Short Interest Nuvalent Short Interest Axsome Therapeutics Short Interest CRISPR Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ANIP) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump's "Big Beautiful Bill" hides ugly truthWashington’s new “Big Beautiful Bill” promises tax breaks… but the fine print tells a different story: trillio...Defi Master | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ANI Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ANI Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access